| | DEVELOPMENT OF REGULATIONS GOVERNING MEDICAL RESEARCH |
| | 1,82 | | MB | WITH PSYCHEDELICS AND MARIJUANA IN THE U.S. |
| | 369 | | stron |
| | 4608 | | ID | Food and Drug Administration |
| | 2001 | | rok |
| | CHAPTER 1 |
| | THE EVOLUTION OF THE REGULATION OF THE MEDICAL USES OF PSYCHEDELIC DRUGS |
| | AND MARIJUANA |
| | CHAPTER 2 |
| | FROM PILOT DRUG TO THE PRESENT |
| | CHAPTER 3 |
| | THE RISE AND FALL OF FDA’S PILOT DRUG EVALUATION STAFF |
| | CHAPTER 4 |
| | REGULATORY, ETHICAL AND METHODOLOGICAL ISSUES IN PSYCHEDELIC RESEARCH |
| | CHAPTER 5 |
| | ENHANCED PROTOCOL DESIGNS FOR EVALUATING PSYCHEDELIC PSYCHOTHERAPY |
| | CHAPTER 6 |
| | REGULATION OF THE PRESCRIPTION USE OF PSYCHEDELICS |